BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fourzali K, Yosipovitch G. Safety considerations when using drugs to treat pruritus. Expert Opin Drug Saf 2020;19:467-77. [PMID: 32064980 DOI: 10.1080/14740338.2020.1728252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ingrasci G, Lipman ZM, Yosipovitch G. When topical therapy of atopic dermatitis fails: a guide for the clinician. Expert Rev Clin Immunol 2021;:1-12. [PMID: 34720031 DOI: 10.1080/1744666X.2021.2000390] [Reference Citation Analysis]
2 Lipman ZM, Labib A, Yosipovitch G. Current Clinical Options for the Management of Itch in Atopic Dermatitis. Clin Cosmet Investig Dermatol 2021;14:959-69. [PMID: 34377004 DOI: 10.2147/CCID.S289716] [Reference Citation Analysis]
3 Crowley EL, Nezamololama N, Papp K, Gooderham MJ. Abrocitinib for the treatment of atopic dermatitis. Expert Rev Clin Immunol 2020;16:955-62. [PMID: 32969750 DOI: 10.1080/1744666X.2021.1828068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]